The UK Country Manager of Pfizer, Ben Osborn, has been appointed as the new President of the Association of the British Pharmaceutical Industry (ABPI). Pinder Sahota, General Manager of Novo Nordisk, has been appointed as Vice President.
Osborn will take over from Hasseb Ahmad and will lead on overseeing the ABPI, the ABPI Board, and the ABPI’s Code of Practice, which is administered by the Prescription Medicines Code of Practice Authority (PMCPA).
His presidency will have three broad priorities: Building a more resilient NHS post-pandemic, working to make life sciences a focus of the UK’s future prosperity and tackling global health challenges to find solutions for ongoing health emergencies and to be prepared for future pandemics.
